Olfactory mucosa-derived mesenchymal stem cell therapy(Institute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus)

N/A

Report date: 2023/01/12 15:40:57

Base Information

Drug NameOlfactory mucosa-derived mesenchymal stem cell therapy(Institute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Olfactory mucosa-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsTracheal StenosisLaryngostenosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelarus

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

Inactive CompaniesN/A

Active IndicationsTracheal StenosisLaryngostenosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A